Prices delayed by at least 15 minutes | Print


Aflac (AFL)

Common Stock
Sell: $83.23|Buy: $84.44|Change: 2.25 (2.78%)

Open 

$81.47


Previous close 

$80.98


Trade high 

$83.545


Volume 

6,558,436


Year high 

$86.26


Year low 

$64.10


Dividend yield 

2.17%


Market capitalisation 

$47.89 bn


P/E ratio 

10.41


ISIN 

US0010551028


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date15/11/202321/02/2024
Ex-dividend date14/11/202320/02/2024
Payment date01/12/202301/03/2024
Amount$0.42$0.5

Performance 19/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Aflac+ 2.78
More...

Company profile

Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Sector 

Financial Services


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.